Butterfly Network (BFLY) Stock Sinks As Q3 Results Fuel Valuation Debate

Butterfly Network just reported its Q3 2026 numbers and the stock dropped sharply. The share price closed at US$6.39, down 14.9% for the day, while the ultrasound specialist delivered a record adjusted gross margin near 73% and revenue of US$32.6m, which came in above its own guidance range.

The market reaction suggests concern about valuation and future profitability. The financial results point to a different picture, with a significantly narrower adjusted EBITDA loss of US$1.2m and management raising full year revenue and profit guidance. For now, sentiment appears to be driving the share price more than the income statement.

Like Butterfly Network's high gross margin profile but worried about the path to consistent profits after this sharp share price move? Use the 38 profitable AI stocks that aren't just burning cash

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs. Q3 2025): US$32.6m vs. US$21.5m (revenue higher year on year)
• Net Loss (Q3 2026 vs. Q3 2025): US$12.8m loss vs. US$34.0m loss (loss narrowed year on year)
• Basic EPS (Q3 2026 vs. Q3 2025): US$0.05 loss per share vs. US$0.13 loss per share (per share loss reduced year on year)
• Adjusted Gross Margin (Q3 2026 vs. Q3 2025): approximately 73% vs. a lower level in the prior period (margin reached a company record)

Earnings are telling one story for Butterfly Network, but investors who care about what they are paying often focus on the cash flowing through the business instead of the income statement alone. Based on Butterfly Network's own cash flows, the stock could be a mild 8% overvalued.

Butterfly Network’s Platform Pitch Meets Concrete Milestones

The bullish story hinges on Butterfly Network turning chips and software into the main engine of the business.

"Bullish analysts expect Butterfly Network to compound its Ultrasound-on-Chip platform, Embedded partnerships, and AI software into a higher-margin business that supports a sustained shift toward enterprise healthcare and broader ultrasound adoption."

Q3 gives that idea real footing. Embedded revenue reached US$11.1m with contributions from partners like Midjourney, Merge Labs and Bridge Neurotech, and the first commercial Embedded product shipped. Record adjusted gross margin near 73% and five seven figure total contract value software and Compass AI deals show that enterprise and licensing are now moving the needle rather than handheld probe volume alone.

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.

Butterfly Network’s Execution Risks Still On Display

Bearish investors worry that Butterfly Network’s new engines will not scale smoothly enough to support the recent optimism.

"Although Butterfly Network highlights its Ultrasound on Chip platform and a growing set of Embedded partnerships as a long term growth engine, the concentration of recent Embedded revenue around a single Midjourney agreement worth up to US$74 million raises the risk that slower ramp or renewal from this partner, or limited follow through from the other 10 Embedded deals, could leave overall revenue and earnings meaningfully below what the current share price appears to assume."

Q3 Embedded sales of US$11.1m plus new Merge Labs and Bridge Neurotech contributions show the chip model working, yet management flags milestone driven lumpiness and refuses customer level disclosure. International revenue is still soft and Home & Community Care has not booked its first dollar yet. That combination means partner and geography concentration remain unresolved, even with raised 2026 guidance and narrower adjusted EBITDA loss.

Hunt For Mispriced Stories

Butterfly Network’s latest quarter shows how sentiment can move faster than the underlying numbers. The real opportunity could be spotting stocks that look misaligned before expectations reset.

• Company 1 - 19% below our estimate - expands franchised and company-run teahouses while testing whether overseas GMV momentum can support healthier unit economics.
• Company 2 - 31% below our estimate - supplies AI infrastructure superclusters that a leading model provider now uses to extend its primary cloud platform.
• Company 3 - 34% below our estimate - converts long term optical and solar supply agreements into production tied to data center and clean energy buildouts.

Three companies from the same screener. Open the full list of 30 companies trading below our fair value estimates →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com